KEYNOTE-040: groundbreaking results for pembrolizumab in head and neck cancer
Breathlessness in lung cancer: increasing awareness
Robot-assisted surgery – what are the advantages for clinicians and patients?
Improved survival, toxicity & QoL with pembrolizumab in head and neck cancer
The development of immunotherapies in the treatment of relapsed metastatic head and neck cancer